MiniMed Group Inc (NASDAQ:MMED - Get Free Report)'s share price rose 6.7% during mid-day trading on Friday . The stock traded as high as $16.88 and last traded at $16.94. 1,230,110 shares changed hands during mid-day trading, an increase of 26% from the average session volume of 973,886 shares. The stock had previously closed at $15.88.
Wall Street Analyst Weigh In
Several research analysts have commented on MMED shares. William Blair initiated coverage on MiniMed Group in a report on Tuesday, March 31st. They set an "outperform" rating on the stock. The Goldman Sachs Group began coverage on MiniMed Group in a report on Tuesday, March 31st. They set a "buy" rating and a $24.00 target price for the company. Morgan Stanley assumed coverage on shares of MiniMed Group in a research report on Tuesday, March 31st. They set an "overweight" rating and a $19.00 price target on the stock. BTIG Research began coverage on MiniMed Group in a research report on Tuesday, March 31st. They set a "buy" rating and a $25.00 target price on the stock. Finally, Evercore assumed coverage on MiniMed Group in a research note on Tuesday, March 31st. They set an "outperform" rating and a $20.00 price objective for the company. Twelve analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $21.33.
Check Out Our Latest Report on MMED
MiniMed Group Trading Up 4.5%
The stock has a market cap of $4.66 billion and a PE ratio of -24.47. The firm has a 50 day simple moving average of $13.66.
MiniMed Group (NASDAQ:MMED - Get Free Report) last announced its quarterly earnings results on Wednesday, June 3rd. The company reported ($0.68) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by ($0.46). The company had revenue of $837.00 million during the quarter. The firm's revenue for the quarter was up 15.6% compared to the same quarter last year.
MiniMed Group Company Profile
(
Get Free Report)
We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MiniMed Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MiniMed Group wasn't on the list.
While MiniMed Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
